Why RYTM was halted on Nov 4 2026: nice positive guidance
RYTM+21.7%on Wed Nov 4 2026
Rhythm Pharmaceuticals, Inc. Common Stock was up 21.7% on the day at $105.17, ranked #1 on 8.3× its usual five-minute volume, when TapeRank recorded this trading halt at 15:58 ET during regular hours when it was halted. TapeRank recorded 2 events for RYTM that day, between 15:58 and 15:58 ET, and each is in the timeline below.
THE DAY ON THE LIST · 2 EVENTS
- 15:58 ETMOVER · REGULAR
$105.17 · ▲ 21.7% ON THE DAY · 8.6× 5M RVOL · RANK #1
JUSTIFIEDCONFIDENCE4/5RYTM is up 21.7%, with a sharp late acceleration, after NICE issued positive guidance expanding IMCIVREE access to adults with genetically confirmed Bardet-Biedl syndrome. The analyst price-target increase reinforces the move, and the regulatory access decision is a concrete commercial catalyst for a rare-disease biotech.
WHYA 21.7% move is large, but it is proportionate to positive reimbursement/access guidance that expands the eligible IMCIVREE market, reinforced by a target increase to $166.ANALYZED 15:58 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNATHE ROW AND SESSION LEVELS AT 15:58 ET
LAST105.17DAY▲ 21.7%5 MIN▲ 10.30%5M RVOL8.6×5M $VOL$38.3MFLOAT*68.5MRANK#1SESSIONREGULARVWAP92.38HOD105.17LOD85.04OR HIGH87.77OR LOW85.94PREV CLOSE86.44PM HIGH85.70PM LOW85.70GAP▼ 0.58%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
- 15:58 ETHALT · REGULAR
HALTED AT $105.17 · ▲ 21.7% ON THE DAY · 8.3× 5M RVOL · RANK #1
The same verdict as at 15:58 ET.
THE ROW AND SESSION LEVELS AT 15:58 ET
LAST105.17DAY▲ 21.7%5 MIN▲ 10.30%5M RVOL8.3×5M $VOL$38.3MFLOAT*68.5MRANK#1SESSIONREGULARVWAP92.38HOD105.17LOD85.04OR HIGH87.77OR LOW85.94PREV CLOSE86.44PM HIGH85.70PM LOW85.70GAP▼ 0.58%* FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE
THE SESSION
- 09:30 ETOpened at $85.94, -0.6% on the previous close of $86.44
- 10:03 ETRegular-session low, $85.04
- 15:57 ETRegular-session high, $105.17
- 15:57 ETLast trade of the regular session, $105.17, +21.7% on the previous close of $86.44
- 15:57 ETHalted (LUDP); resumed 16:00 ET, after 2 minutes
- Volume: 3.7M shares in regular hours, 100 before the open
FILINGS AND NEWS · 24H BEFORE THE MOVE
- 08:53 ETCitizens Maintains Market Outperform on Rhythm Pharmaceuticals, Raises Price Target to $166Benzinga
- 08:03 ETRhythm Pharmaceuticals Receives Positive Guidance For IMCIVREE From National Institute For Health And Care Excellence To Add Adults With Bardet-Biedl SyndromeBenzinga
- TUE 16:08 ET10-Q — Quarterly reportSEC 10-Q
On the tape right now
WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY
Open the full list